Dr. Stephan Busque, MD, MS
Claim this profileStanford University
Studies Immune Tolerance
Studies Determination of Death
6 reported clinical trials
10 drugs studied
Area of expertise
1Immune Tolerance
HLA-A positive
HLA-A negative
HLA positive
2Determination Of Death
Affiliated Hospitals
Clinical Trials Stephan Busque, MD, MS is currently running
Hematopoietic Cell Transplantation
for Immune Tolerance in Kidney Transplant Recipients
The study will determine whether patients with functioning Human Leukocyte Antigen (HLA) matched kidney transplants for at least one year and who want to discontinue immunosuppressive drugs can be treated with Total Lymphoid Irradiation (TLI) and rabbit Anti-Thymocyte Globulin (rATG) and an HLA matched donor hematopoietic progenitor cell infusion such that their drugs are successfully withdrawn while maintaining normal renal function.
Recruiting1 award Phase 12 criteria
Stem Cell + Treg Therapy
for Kidney Transplant
This study will determine whether a preparatory regimen including total lymphoid irradiation (TLI), total body irradiation (TBI), anti-thymocyte globulin (ATG) and infusion of the donor hematopoietic stem cells when given along with recipient regulatory T cells (Tregs) will allow for eventual discontinuation of anti-rejection drugs after living donor kidney transplantation.
Recruiting1 award Phase 14 criteria
More about Stephan Busque, MD, MS
Clinical Trial Related14 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Stephan Busque, MD, MS has experience with
- Donor Derived Vertebral Bone Marrow Infusion
- Recipient T Regulatory Cell Infusion
- Donor Stem Cells
- Combined Deceased Donor Kidney And Hematopoietic Cell Transplants
- Infusion Of Donor Hematopoetic Stem Cells
- Recipient Tregs
Breakdown of trials Stephan Busque, MD, MS has run
Immune Tolerance
Determination of Death
Islet Transplantation
Renal Disease
Kidney Transplant
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephan Busque, MD, MS specialize in?
Stephan Busque, MD, MS focuses on Immune Tolerance and Determination of Death. In particular, much of their work with Immune Tolerance has involved HLA-A positive patients, or patients who are HLA-A negative.
Is Stephan Busque, MD, MS currently recruiting for clinical trials?
Yes, Stephan Busque, MD, MS is currently recruiting for 2 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Stephan Busque, MD, MS has studied deeply?
Yes, Stephan Busque, MD, MS has studied treatments such as Donor Derived Vertebral Bone Marrow infusion, Recipient T regulatory cell infusion, Donor Stem Cells.
What is the best way to schedule an appointment with Stephan Busque, MD, MS?
Apply for one of the trials that Stephan Busque, MD, MS is conducting.
What is the office address of Stephan Busque, MD, MS?
The office of Stephan Busque, MD, MS is located at: Stanford University, Palo Alto, California 94305 United States. This is the address for their practice at the Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.